Noha A. Ahmed
Bani Suwayf, BNS 62521, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Disrupting the tumor-associated TNKS-USP25 protein-protein interface in cancer: structural basis, druggability, and therapeutic opportunities.
Journal: RSC advances
Published: February 15, 2026
Protein-protein interaction disruption as a next-generation antithrombotic strategy.
Journal: Journal of thrombosis and thrombolysis
Published: February 11, 2026
Disrupting E3 ubiquitin ligase protein-protein interactions in cancer: chemical modalities, mechanisms, and therapeutic opportunities.
Journal: Biochemical pharmacology
Published: January 29, 2026
Disrupting the CBFβ-SMMHC-RUNX1 oncogenic protein-protein interaction in inv(16) AML: from fusion biology to targeted therapy.
Journal: Discover oncology
Published: January 26, 2026
CBFβ-SMMHC in inv(16) AML: Fusion biology, RUNX1 dysregulation, and therapeutic targeting of a leukemogenic protein-protein interaction.
Journal: Pathology, research and practice
Published: January 20, 2026
Disrupting PQBP1-eEF2 protein-protein interaction: From synaptic translation to immunity and cancer.
Disrupting PQBP1-eEF2 protein-protein interaction: From synaptic translation to immunity and cancer.
Journal: Neurochemistry international
Published: January 19, 2026
The CLOCK-BMAL1 complex in circadian regulation: structure, mechanisms, and therapeutic targeting.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: January 14, 2026
Evaluation of the anti-hyperglycemic, anti-hyperlipidemic, cardioprotective and anti-inflammatory effects of a xanthine-based dipeptidyl peptidase-4 inhibitor and diosmin in NA/STZ-induced diabetic rats.
Journal: Archives of physiology and biochemistry
Published: January 08, 2026
Chemerin Normal Function and Roles in Metabolic and Nonmetabolic Disorders: An Up-To-Date Comprehensive Review.
Journal: Biochemistry research international
Published: December 22, 2025
Genotoxicity and DNA Damage in Long-Term SSRI Therapy: A Review Across SSRIs With Citalopram as a Case Study.
Journal: Journal of applied toxicology : JAT
Published: December 09, 2025
From In Vitro Genotoxicity Assays to Human Biomarkers: Interpreting DNA Damage Signals in Long-Term SSRI Therapy through a Translational Neurotoxicology Lens.
Journal: Neurotoxicity research
Published: December 05, 2025
Targeting the Elongin BC-BC-Box Interface: Structural Insights, Peptidic Disruptors and Emerging Small-Molecule Strategies.
Journal: Chemical biology & drug design
Published: November 30, 2025
Last Updated: 09/26/2026